Drug Companies Face Hostility as They Hope for Allies Among Trump’s Health Picksnews2024-11-28T02:32:29+00:00November 28th, 2024|The New York Times|
Dr Martin Makary Chosen to Head the FDAnews2024-11-23T02:15:50+00:00November 23rd, 2024|The New York Times|
Orders for Morning-After Pills and Abortion Pills Rise After Trump’s Electionnews2024-11-19T10:03:41+00:00November 19th, 2024|The New York Times|
Kennedy’s Views Mix Mistrust of Business With Unfounded Health Claimsnews2024-11-16T03:21:15+00:00November 16th, 2024|The New York Times|
Don’t Blame Biden for Trump’s Victorynews2024-11-15T15:38:02+00:00November 15th, 2024|The New York Times|
Robert F. Kennedy Jr.’s Billion-Dollar Hit to Big Pharmanews2024-11-15T15:20:47+00:00November 15th, 2024|The New York Times|
What Democrats Should Learn From Their Lossnews2024-11-13T16:49:52+00:00November 13th, 2024|The New York Times|
Robert F. Kennedy Jr. se prepara para ejercer el poder en salud públicanews2024-11-07T08:05:06+00:00November 7th, 2024|The New York Times|
Robert F. Kennedy Jr., Foe of Drug Makers and Regulators, Is Poised to Wield New Powernews2024-11-06T22:09:44+00:00November 6th, 2024|The New York Times|
How a Second Trump Term Could Recast Public Healthnews2024-11-01T01:21:05+00:00November 1st, 2024|The New York Times|
